Compounds for inhibiting beta-amyloid peptide release and/or its synthesis

Disclosed are compounds which inhibit beta-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits beta-amyloid peptide release and/or its synthesis.

Saved in:
Bibliographic Details
Main Authors REEL JON K, FOLMER BEVERLY K, DROSTE JAMES J, BRITTON THOMAS C, AUDIA JAMES E, WU JING, MABRY THOMAS E, TUNG JAY S, PORTER WARREN J, THORSETT EUGENE D, LATIMER LEE H, NISSEN JEFFREY S, JOHN VARGHESE, HUFFMAN GEORGE W
Format Patent
LanguageEnglish
Published 27.03.2001
Edition7
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

Abstract Disclosed are compounds which inhibit beta-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits beta-amyloid peptide release and/or its synthesis.
AbstractList Disclosed are compounds which inhibit beta-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits beta-amyloid peptide release and/or its synthesis.
Author JOHN VARGHESE
PORTER WARREN J
LATIMER LEE H
NISSEN JEFFREY S
THORSETT EUGENE D
DROSTE JAMES J
FOLMER BEVERLY K
HUFFMAN GEORGE W
WU JING
BRITTON THOMAS C
MABRY THOMAS E
REEL JON K
TUNG JAY S
AUDIA JAMES E
Author_xml – fullname: REEL JON K
– fullname: FOLMER BEVERLY K
– fullname: DROSTE JAMES J
– fullname: BRITTON THOMAS C
– fullname: AUDIA JAMES E
– fullname: WU JING
– fullname: MABRY THOMAS E
– fullname: TUNG JAY S
– fullname: PORTER WARREN J
– fullname: THORSETT EUGENE D
– fullname: LATIMER LEE H
– fullname: NISSEN JEFFREY S
– fullname: JOHN VARGHESE
– fullname: HUFFMAN GEORGE W
BookMark eNqNyj0OgkAQBtAttPDvDnMBImgivURjbNWaDO6HTAKzG2YtuL0x8QBWr3lLN9OgWLhrFYYY3uqN2jCSaCeNJNEXNUic8TD1QTxFxCQeNKIHG4jVb789GdmkqYOJrd285d6w-blydD7dq0uGGGpY5CcUqX7cDru8LIv8WOz_KB8CQzbS
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
Edition 7
ExternalDocumentID US6207710B1
GroupedDBID EVB
ID FETCH-epo_espacenet_US6207710B13
IEDL.DBID EVB
IngestDate Fri Jul 19 13:08:55 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US6207710B13
Notes Application Number: US19980164385
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20010327&DB=EPODOC&CC=US&NR=6207710B1
ParticipantIDs epo_espacenet_US6207710B1
PublicationCentury 2000
PublicationDate 20010327
PublicationDateYYYYMMDD 2001-03-27
PublicationDate_xml – month: 03
  year: 2001
  text: 20010327
  day: 27
PublicationDecade 2000
PublicationYear 2001
RelatedCompanies ELI LILLY & COMPANY
ELAN PHARMACEUTICALS, INC
RelatedCompanies_xml – name: ELAN PHARMACEUTICALS, INC
– name: ELI LILLY & COMPANY
Score 2.5215344
Snippet Disclosed are compounds which inhibit beta-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20010327&DB=EPODOC&locale=&CC=US&NR=6207710B1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1NS8Mw9DGmqDedivOLHKS3sq1rk3oowtqOMdgHbpXdRtNmmINZMRXx3_tS1ulFcwpJeDxeeF_J-wB4YL7HRJdmtqAbdFBw2H7fd22v7wi-oSnvVTc9mdJR4o5X3qoBss6FqeqEflbFEZGjMuT3spLXxc8jVlTFVuoOl7i0fRoug8iqvWNTHo5Z0SCI57NoFlphGCQLa_ocUKfLUJkO0FE6MFa0KbMfvwxMUkrxW6MMT-FwjsBUeQYNoVpwHNaN11pwNNn9d-N0x3r6HMaGc00PJE3QziRSvUouTcwy4Yipnb6h5y1zUpgolVwQ0wsFFRRJVd4xx0tN9JdCa09LfQFkGC_DkY1IrfcEWCeLPfr9S2iqrRJXQCgX3E1RPjCeuVnP93OH-Ujgxw3luOa1of0nmOt_9m7gpA60ctgtNMv3D3GHmrfk9xXNvgFsIIlx
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1NT8Iw9IWgEW-KGvGzB7PbAoytnYfFhA2CyFcEDDeybiX2YCF2xvjvfV0YetGemrZ5eXnN-2rfB8Ad8z0mGjSxBV2hg4LD9lu-a3stR_AVjXkzv-nhiPbmbn_hLUogi1yYvE7oZ14cETkqQX7Pcnm9-XnEivLYSl3nEpfWD91ZEFmFd2zKwzEragedyTgah1YYBvOpNXoOqNNgqEzb6CjtMVOc11hOL22TlLL5rVG6R7A_QWAqO4aSUFWohEXjtSocDLf_3Tjdsp4-gb7hXNMDSRO0M4lUr5JLE7NMOGJqx2_oecuUbEyUSiqI6YWCCorEKq2b45km-kuhtaelPgXS7czCno1ILXcEWM6nO_RbZ1BWayXOgVAuuBujfGA8cZOm76cO85HA9yvKcc2rQe1PMBf_7N1CpTcbDpaDx9HTJRwWQVcOu4Jy9v4hrlELZ_wmp983ApKMXg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Compounds+for+inhibiting+beta-amyloid+peptide+release+and%2For+its+synthesis&rft.inventor=REEL+JON+K&rft.inventor=FOLMER+BEVERLY+K&rft.inventor=DROSTE+JAMES+J&rft.inventor=BRITTON+THOMAS+C&rft.inventor=AUDIA+JAMES+E&rft.inventor=WU+JING&rft.inventor=MABRY+THOMAS+E&rft.inventor=TUNG+JAY+S&rft.inventor=PORTER+WARREN+J&rft.inventor=THORSETT+EUGENE+D&rft.inventor=LATIMER+LEE+H&rft.inventor=NISSEN+JEFFREY+S&rft.inventor=JOHN+VARGHESE&rft.inventor=HUFFMAN+GEORGE+W&rft.date=2001-03-27&rft.externalDBID=B1&rft.externalDocID=US6207710B1